The recent instability in global distribution have highlighted the value of securing essential medications like Ivermectin. Dependence on overseas manufacturers exposes nations to potential vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical concerns. Shifting towards domestic procurement of Ivermectin offers